Clinical Trial

Oral Gallium Maltolate for Recurrent Glioblastoma

Name: Oral Gallium Maltolate for Recurrent Glioblastoma — clinical trial record (NCT07515924)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 0 investigational study to assess the central nervous system penetration and tumoral concentration of gallium in patients with recurrent glioblastoma administered with preoperative gallium maltolate.

Trial Details

NCT Number	NCT07515924
Lead Sponsor	Medical College of Wisconsin
Conditions	Glioblastoma
Enrollment	8 participants
Start Date	2026-06
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-04-07